“…Furthermore, midazolam premedication 17,27,30,36,37,39,42,45,46,54,58,62,64,70,74–76,78,79 did not affect the effect size (Supplementary Table S6, http://links.lww.com/EJA/A522). In the sensitivity analysis, following exclusion of studies that were considered to have a high risk of bias, 10,30,36,40,46,47,49,51–54,56,60,62,66–68,70,73,76,79,80 there was no significant change in the results of the NMA comparing adjuvant dexmedetomidine and TIVA (Supplementary Table S6, http://links.lww.com/EJA/A522; see Supplementary Fig. S12 for network diagrams for the subgroup and sensitivity analyses, http://links.lww.com/EJA/A522).…”